SARS-CoV-2 vaccine

The accelerated response to Covid-19 includes investments in preclinical and clinical testing and manufacture of multiple vaccine candidates.

There is a large global effort to develop vaccines for protection against 新冠肺炎 and at least 19 vaccine candidates.

A COVID‑19 vaccine is a biotechnology product intended to provide acquired immunity against coronavirus disease 2019 (COVID‑19)